Communication unit and Human resources management sector - shared assignment traineeship - European Union Drugs Agency (Lisbon)

About this position

The summary below is published by European Union Drugs Agency on the official vacancy notice. Our own analysis — salary realism, comparable openings, career trajectory, language profile — follows further down the page.

Position details

Reference

TR/2027/02

Last Verified

24 July 2026

Position overview

This is the official EU Careers listing for Communication unit and Human resources management sector - shared assignment traineeship at EUDA based in Lisbon (Traineeship). The vacancy reference is TR/2027/02.

[Skip to main content](https://www.euda.europa.eu/calls/2026/tr202702_en#main-content)

[Homepage](https://www.euda.europa.eu/)

[Quick links](https://www.euda.europa.eu/calls/2026/tr202702_en#block-block-menu-quick-links-menu)

## Quick links

* [Campaigns](https://www.euda.europa.eu/activities/campaigns_en "Currently active EMCDDA campaigns") * [Cannabis policy: recent developments](http://www.emcdda.europa.eu/topics/cannabis-policy) * [Data catalogue](https://www.euda.europa.eu/data/data-catalogue_en) * [Document library](https://www.euda.europa.eu/document-library_en "EMCDDA repository's of useful documents, mainly published by third-parties but also EMCDDA working documents etc.") * [Drug profiles](http://www.emcdda.europa.eu/drug-profiles) * [EU Early Warning System (EWS) on NPS](https://www.euda.europa.eu/archived/publications/topic-overviews/eu-early-warning-system_en) * [ESPAD](http://www.espad.org/) * [EU Drug Markets: In-depth analysis](https://www.euda.europa.eu/publications/eu-drug-markets_en) * [European Drug Report](https://www.euda.europa.eu/publications/european-drug-report/2026_en) * [European Responses Guide](https://www.euda.europa.eu/publications/manuals/european-responses-guide_en) * [Lisbon addictions](https://www.lisbonaddictions.eu/) * [Media library](https://www.euda.europa.eu/media-library_en) * [Network of labs](https://www.euda.europa.eu/activities/network-of-labs_en) * [Partners](http://www.emcdda.europa.eu/about/partners) * [Statistical Bulletin](https://www.euda.europa.eu/data/stats2026_en) * [Toolkits](https://www.euda.europa.eu/publications-database_en?f%5B0%5D=publication_type%3A3305 "Toolkits published by the EUDA") * [Web archive (up to 2 July 2024) — EMCDDA](https://wayback.archive-it.org/12090/*/https://www.emcdda.europa.eu/ "Official archive of the EMCDDA website (up to 2 July 2024), archived by the Publications Office of the European Union") * [Web archive (from 2 July 2024) — EUDA](https://wayback.archive-it.org/12090/*/https:/www.euda.europa.eu/ "Official archive of the EUDA website (from 2 July 2024), archived by the Publications Office of the European Union")

[](https://www.euda.europa.eu/calls/2026/tr202702_en#mainNavbar)

[](https://www.euda.europa.eu/index_en "Home")

The European Union Drugs Agency (EUDA)

English EN Select another language

[Toggle search form](https://www.euda.europa.eu/calls/2026/tr202702_en#mainNavbar)

GO Results hosted on duckduckgo.com

GO Results hosted on duckduckgo.com

## Main navigation

* [Data Open related submenu](https://www.euda.europa.eu/data_en)

### [Data](https://www.euda.europa.eu/data_en)

 Explore the most recent data on the drug situation in Europe provided by the EU Member States. These datasets underpin the analysis presented in the agency's work. Most data may be viewed interactively on screen and downloaded in Excel format.

[Data](https://www.euda.europa.eu/data_en)

### Latest data

* [Statistical Bulletin 2026 home](https://www.euda.europa.eu/data/stats2026_en) * [Prevalence of drug use](https://www.euda.europa.eu/data/stats2026/gps_en) * [Drug-induced deaths](https://www.euda.europa.eu/data/stats2026/drd_en) * [Infectious diseases](https://www.euda.europa.eu/data/stats2026/drid_en) * [Problem drug use](https://www.euda.europa.eu/data/stats2026/pdu_en) * [Treatment demand](https://www.euda.europa.eu/data/stats2026/tdi_en) * [Seizures of drugs](https://www.euda.europa.eu/data/stats2026/szr_en) * [Price, purity and potency](https://www.euda.europa.eu/data/stats2026/ppp_en)

* [Drug use and prison](https://www.euda.europa.eu/data/stats2026/dup_en) * [Drug law offences](https://www.euda.europa.eu/data/stats2026/dlo_en) * [Health and social responses](https://www.euda.europa.eu/data/stats2026/hsr_en) * [Drug checking (TEDI)](https://www.euda.europa.eu/data/stats2026/drug-checking_en) * [Hospital emergencies (Euro-DEN Plus)](https://www.euda.europa.eu/data/stats2026/hospital-emergencies_en) * [Syringe residues (ESCAPE)](https://www.euda.europa.eu/data/stats2026/syringe-residues_en) * [Wastewater analysis (SCORE)](https://www.euda.europa.eu/publications/html/pods/waste-water-analysis_en) * [Data catalogue](https://www.euda.europa.eu/data/data-catalogue_en)

* [Countries Open related submenu](https://www.euda.europa.eu/countries_en)

### [Countries](https://www.euda.europa.eu/countries_en)

 We work closely with the 27 EU Member States plus Norway and Türkiye, candidates and potential candidates to the EU, the European Neighbourhood Policy countries and other third countries.

[Countries](https://www.euda.europa.eu/countries_en)

### Reporting countries

* [Austria](https://www.euda.europa.eu/about/partners/reitox/austria_en) * [Belgium](https://www.euda.europa.eu/about/partners/reitox/belgium_en) * [Bulgaria](https://www.euda.europa.eu/about/partners/reitox/bulgaria_en) * [Croatia](https://www.euda.europa.eu/about/partners/reitox/croatia_en) * [Cyprus](https://www.euda.europa.eu/about/partners/reitox/cyprus_en) * [Czechia](https://www.euda.europa.eu/about/partners/reitox/czechia_en) * [Denmark](https://www.euda.europa.eu/about/partners/reitox/denmark_en) * [Estonia](https://www.euda.europa.eu/about/partners/reitox/estonia_en) * [Finland](https://www.euda.europa.eu/about/partners/reitox/finland_en) * [France](https://www.euda.europa.eu/about/partners/reitox/france_en)

* [Germany](https://www.euda.europa.eu/about/partners/reitox/germany_en) * [Greece](https://www.euda.europa.eu/about/partners/reitox/greece_en) * [Hungary](https://www.euda.europa.eu/about/partners/reitox/hungary_en) * [Ireland](https://www.euda.europa.eu/about/partners/reitox/ireland_en) * [Italy](https://www.euda.europa.eu/about/partners/reitox/italy_en) * [Latvia](https://www.euda.europa.eu/about/partners/reitox/latvia_en) * [Lithuania](https://www.euda.europa.eu/about/partners/reitox/lithuania_en) * [Luxembourg](https://www.euda.europa.eu/about/partners/reitox/luxembourg_en) * [Malta](https://www.euda.europa.eu/about/partners/reitox/malta_en) * [Netherlands](https://www.euda.europa.eu/about/partners/reitox/netherlands_en)

* [Norway](https://www.euda.europa.eu/about/partners/reitox/norway_en) * [Poland](https://www.euda.europa.eu/about/partners/reitox/poland_en) * [Portugal](https://www.euda.europa.eu/about/partners/reitox/portugal_en) * [Romania](https://www.euda.europa.eu/about/partners/reitox/romania_en) * [Slovakia](https://www.euda.europa.eu/about/partners/reitox/slovakia_en) * [Slovenia](https://www.euda.europa.eu/about/partners/reitox/slovenia_en) * [Spain](https://www.euda.europa.eu/about/partners/reitox/spain_en) * [Sweden](https://www.euda.europa.eu/about/partners/reitox/sweden_en) * [Türkiye](https://www.euda.europa.eu/about/partners/reitox/t%C3%BCrkiye_en)

[All countries](https://www.euda.europa.eu/countries)

* [Topics Open related submenu](https://www.euda.europa.eu/topics_en)

### [Topics](https://www.euda.europa.eu/topics_en)

 Explore the content of our work by topic.

[Topics](https://www.euda.europa.eu/topics_en)

### Selected topics

* [Alternatives to coercive sanctions](https://www.euda.europa.eu/content/alternatives-coercive-sanctions_en) * [Cannabis](https://www.euda.europa.eu/topics/cannabis_en) * [Cannabis policy](https://www.euda.europa.eu/topics/cannabis-policy_en) * [Cocaine](https://www.euda.europa.eu/topics/cocaine_en) * [Darknet markets](https://www.euda.europa.eu/topics/darknet-and-drugs_en) * [Drug checking](https://www.euda.europa.eu/topics/drug-checking_en) * [Drug consumption facilities](https://www.euda.europa.eu/topics/drug-consumption-facilities_en) * [Drug markets](https://www.euda.europa.eu/topics/drug-markets_en) * [Drug-related deaths](https://www.euda.europa.eu/topics/drug-related-deaths_en) * [Drug-related infectious diseases](https://www.euda.europa.eu/topics/drug-related-infectious-diseases_en)

* [Drug markets-related violence](https://www.euda.europa.eu/topics/drug-related-violence-hub-page_en) * [Drugs and driving](https://www.euda.europa.eu/topics/drugs-and-driving_en) * [European Web Survey on Drugs](https://www.euda.europa.eu/topics/european-web-survey-on-drugs_en) * [Gender and drugs](https://www.euda.europa.eu/topics/gender-and-drugs_en) * [Harm reduction](https://www.euda.europa.eu/topics/harm-reduction_en) * [Heroin](https://www.euda.europa.eu/topics/heroin_en) * [Hospital emergencies](https://www.euda.europa.eu/topics/hospital-emergencies_en) * [Law](https://www.euda.europa.eu/topics/law_en) * [Naloxone](https://www.euda.europa.eu/topics/naloxone_en) * [New psychoactive substances (NPS)](https://www.euda.europa.eu/topics/nps_en)

* [Prevalence of drug use](https://www.euda.europa.eu/topics/prevalence-and-patterns-of-drug-use_en) * [Prevention](https://www.euda.europa.eu/topics/prevention_en) * [Prison](h

Application timeline

This vacancy was first listed on 24 July 2026, today.

The application deadline is 25 August 2026, 31 days from today. Late applications are not accepted, so submit through the official EU Careers portal well in advance.

Last verified against the EU Careers feed on 24 July 2026.

Where to learn more

For headcount, mission, and other open vacancies at EUDA see the EUDA institution page; for the cost of living, correction coefficient, and other postings in Lisbon see our Lisbon location page.

New to EU careers? Our beginner's guide walks through entry routes, EPSO competitions, and what to prepare. For application logistics see application tips and EPSO competitions.